Point72 Hong Kong’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,187
Closed -$5K 1849
2022
Q3
$5K Sell
2,187
-19,898
-90% -$66.4K ﹤0.01% 1797
2022
Q2
$50K Buy
22,085
+16,399
+288% +$61.1K ﹤0.01% 1376
2022
Q1
$38K Buy
5,686
+2,684
+89% +$22.9K ﹤0.01% 1414
2021
Q4
$27K Buy
3,002
+804
+37% +$7.47K ﹤0.01% 1495
2021
Q3
$22K Sell
2,198
-5,754
-72% -$63.1K ﹤0.01% 1684
2021
Q2
$102K Buy
+7,952
New +$109K ﹤0.01% 1318
2021
Q1
Sell
-5,662
Closed -$60K 2318
2020
Q4
$60K Buy
5,662
+3,703
+189% +$33.6K ﹤0.01% 1180
2020
Q3
$15K Buy
+1,959
New +$14.4K ﹤0.01% 927
2020
Q1
Sell
-3,615
Closed -$38K 1469
2019
Q4
$38K Buy
+3,615
New +$32.1K 0.01% 749
2019
Q3
Sell
-833
Closed -$8K 1440
2019
Q2
$8K Buy
+833
New +$8.69K ﹤0.01% 878
2018
Q2
Sell
-2,775
Closed -$43K 1265
2018
Q1
$43K Buy
2,775
+1,549
+126% +$25.9K 0.02% 489
2017
Q4
$20K Buy
+1,226
New +$23.7K 0.02% 371
2016
Q4
Sell
-900
Closed -$22K 1086
2016
Q3
$22K Buy
+900
New +$23.9K 0.01% 575

Other funds holding DBD

Point72 Hong Kong's DBD Position: Q4 2022 in Review

Point72 Hong Kong sold out of Diebold Nixdorf Incorporated (DBD) in Q4 2022, closing a stake of 2,187 shares — an estimated $5K sold.

Point72 Hong Kong first reported a position in DBD in Q3 2016 and held it in 13 quarters. The position peaked at $102K in Q2 2021. 148 funds tracked by Wall St. Rank hold DBD as of Q4 2022.

  • Point72 Hong Kong reported no remaining Diebold Nixdorf Incorporated position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 2,187 Diebold Nixdorf Incorporated shares in Q4 2022, an estimated $5K.
  • Point72 Hong Kong first reported a position in Diebold Nixdorf Incorporated in Q3 2016 and held it in 13 quarters.
  • Point72 Hong Kong's Diebold Nixdorf Incorporated position peaked at $102K in Q2 2021.
  • 148 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.